NKMAX Co., Ltd.
Develops NK cell-based therapies, diagnostics, and biological products.
182400 | KO
Overview
Corporate Details
- ISIN(s):
- KR7182400002
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 돌마로 172 정자동, 헬스케어혁신파크 1층및6층, 성남시
- Website:
- https://nkmax.com/
- Sector:
- Manufacturing
Description
NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-06-23 00:00 |
기업설명회(IR)개최
|
Korean | 7.4 KB | ||
| 2020-06-23 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.5 KB | ||
| 2020-06-22 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 24.9 KB | ||
| 2020-06-17 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 113.5 KB | ||
| 2020-06-17 00:00 |
주식매수선택권부여에관한신고
|
Korean | 15.4 KB | ||
| 2020-06-02 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 91.3 KB | ||
| 2020-05-27 00:00 |
증권발행결과(자율공시)(제10회차 CB)
|
Korean | 6.4 KB | ||
| 2020-05-26 00:00 |
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 51.3 KB | ||
| 2020-05-25 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 39.0 KB | ||
| 2020-05-21 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 113.5 KB | ||
| 2020-05-15 00:00 |
기타경영사항(자율공시)(전환사채 취득 후 재매각의 건)
|
Korean | 8.7 KB | ||
| 2020-05-15 00:00 |
분기보고서 (2020.03)
|
Korean | 1.1 MB | ||
| 2020-05-12 00:00 |
[기재정정]전환사채(해외전환사채포함)발행후만기전사채취득(제7회차)
|
Korean | 17.4 KB | ||
| 2020-05-07 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 15.0 KB | ||
| 2020-05-04 00:00 |
증권발행결과(자율공시)(제9회차 CB)
|
Korean | 6.0 KB |
Automate Your Workflow. Get a real-time feed of all NKMAX Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NKMAX Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NKMAX Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
